-
Next challenge, make vaccines work against new variants: Adar Poonawalla
A lot of sacrifices were made to put the company's focus on Covishield
-
Serum Institute to start manufacturing Sputnik vaccine in September
As part of the technology transfer process, SII has already received cell and vector samples from the Gamaleya Center.
-
Serum Institute seeks test licence from DCGI to manufacture Covid vaccine Sputnik V
Russia's Sputnik V vaccine is currently being manufactured in India by Dr Reddy's Laboratories
-
Covid-19 Vaccine: Serum Institute seeks test licence from DCGI to manufacture Sputnik V
The Serum Institute of India (SII) has put up an application to the Drugs Controller General of India seeking permission for a test licence to manufac
-
Karnataka receives 3 lakh Covishield vaccines from Centre
Karnataka has received 3 lakh doses of Covishield today under the Central quota
-
Covishield: Kerala receives 3.5 lakh vaccine doses
The state government has placed an order for over one crore doses of vaccine to accelerate the vaccination drive in the state.
-
Covaxin: Twitterati spill anger over Bharat Biotech’s Covaxin pricing
Majority of the Indian twitter users have expressed their anger on social media over variation in the costs of vaccine set for people.
-
Serum Institute of India defends Covid vaccine pricing, says initial rates based on advance funding
SII, which manufactures AstraZeneca's vaccine Covishield at its Pune facility, earlier this week announced a price of Rs 600 per dose and at Rs 400 fo
-
Covid-19 vaccine: Centre’s flexible pricing policy will harm the public; earn producers super profits
By leaving the poor to the mercy of impecunious or uncaring state governments and profit-maximising private hospitals, the Centre has failed to live u
-
Covishield comprises over 90% of 12.76 crore COVID vaccines administered so far
Experts said Covishield is being produced at a much higher scale than Covaxin due to which its availability is more
